Mayo Clinic Tests Heat Therapy for Stage 4 Cancer

Imagine treating Stage 4 cancer in five minutes without the brutal side effects of chemotherapy or radiation.

Mayo Clinic is now making that vision a reality through human trials of electromagnetic hyperthermia, a groundbreaking treatment developed by oncology company New Phase. The therapy uses targeted heat injections to stabilize and manage solid tumors in patients with ovarian, cervical, and liver cancers.

The treatment marks a dramatic shift from current cancer care. Each round involves just three to four non-invasive sessions lasting five minutes each. Patients could avoid the nausea, hair loss, fatigue, and other toxic effects that often make traditional cancer treatment nearly as devastating as the disease itself.

"The cancer is like a pandemic. The number is just growing," said Ofer Shalev, New Phase's Founder and CEO. "I'm very happy for the cooperation between New Phase and Mayo Clinic because I feel it's a very good way to cooperate and bring some solution to so many patients at the end of the day."

The timing couldn't be more critical. Cancer remains the second-leading cause of death worldwide, with millions of families watching loved ones endure grueling treatment regimens. Stage 4 diagnoses, in particular, have historically meant focusing on quality of life over cure.

That's exactly what makes this approach so promising. By targeting tumors with heat rather than systemic chemicals or radiation, the treatment aims to attack cancer cells while leaving healthy tissue largely untouched.

The partnership between New Phase and Mayo Clinic combines innovative biotech with one of the world's most respected medical institutions. Mayo's reputation for rigorous testing means the trials will generate reliable data on whether electromagnetic hyperthermia can deliver on its potential.

The Ripple Effect

If successful, this treatment could transform cancer care far beyond the patients in these initial trials. Shorter, gentler treatments mean less time away from work and family. Fewer side effects mean maintaining strength and normalcy during treatment. For healthcare systems, five-minute sessions could treat more patients with fewer resources.

The technology could eventually expand to other cancer types, offering hope to even more patients facing difficult diagnoses. Each successful trial brings researchers closer to understanding how heat therapy might fit into comprehensive cancer treatment plans.

Human trials represent years of development finally reaching the people who need it most. For patients running out of options, new possibilities matter deeply.

Cancer may be growing worldwide, but so are the tools to fight it.